An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Attention Deficit/Hyperactivity Disorder
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 125
- Locations
- 1
- Primary Endpoint
- Adherence to Stimulants
- Last Updated
- 4 years ago
Overview
Brief Summary
This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD).
Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.
Investigators
Joseph Biederman, MD
Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD
Massachusetts General Hospital
Eligibility Criteria
Inclusion Criteria
- •Male and female adults 18 to 55 years
- •A diagnosis of Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-V) Attention Deficit Hyperactivity Disorder based on clinical assessment
- •Is starting stimulant medication or has begun treatment with stimulant medication within six months of study enrollment
- •Proficient in English
- •Has a cellular phone with text messaging capabilities and is interested in and willing to receive text messages
Exclusion Criteria
- •Serious chronic medical or psychiatric condition that, in the investigator's opinion, puts the subject at risk for taking a stimulant
- •Pregnant or nursing females
- •Investigator and his/her immediate family
- •Unwilling/unable to comply with study procedures
Outcomes
Primary Outcomes
Adherence to Stimulants
Time Frame: 9 months
Adherence will be analyzed using the timeliness of stimulant medication prescription renewals over the 9 month period.